1. Indoleamine 2,3-Dioxygenase (IDO) and Cancerous Cells
   Amir Reza Safdarian et al, 2023, Handbook of Cancer and Immunology CrossRef
2. Inhibitory checkpoint molecule mRNA expression in canine soft tissue sarcoma
   Valentina Beatriz Stevenson et al, 2023, Veterinary and Comparative Oncology CrossRef
3. Advances in plant-derived natural products for antitumor immunotherapy
   Yi Yang et al, 2021, Archives of Pharmacal Research CrossRef
4. Construction of a Novel Signature and Prediction of the Immune Landscape in Soft Tissue Sarcomas Based on N6-Methylandenosine-Related LncRNAs
   Li Zhang et al, 2021, Frontiers in Molecular Biosciences CrossRef
5. DDIT3-amplified or low-polysomic pleomorphic sarcomas without MDM2 amplification: Clinicopathological review and immunohistochemical profile of nine cases
   Taro Mori et al, 2024, Human Pathology CrossRef
6. The association between the expression of PD-L1 and CMTM6 in undifferentiated pleomorphic sarcoma
   Shin Ishihara et al, 2021, Journal of Cancer Research and Clinical Oncology CrossRef
7. Retroperitoneal undifferentiated pleomorphic sarcoma with total nephrectomy: a case report and literature review
   Kai Yu et al, 2023, Frontiers in Surgery CrossRef
8. Immunohistochemical Characteristics of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma: A Systematic Review and Meta-Analysis
   Mathias Ørholt et al, 2022, The American Journal of Dermatopathology CrossRef
9. Tumor and Peripheral Immune Status in Soft Tissue Sarcoma: Implications for Immunotherapy
   Luana Madalena Sousa et al, 2021, Cancers CrossRef
10. Prognostic role of indoleamine 2,3-dioxygenase 1 expression in solid tumors: A systematic review and meta-analysis
    Haiyan Zhang et al, 2022, Frontiers in Oncology CrossRef
11. Interactions of IDO and the Kynurenine Pathway with Cell Transduction Systems and Metabolism at the Inflammation–Cancer Interface
    Trevor W. Stone et al, 2023, Cancers CrossRef
12. Soft Tissue Leiomyosarcoma With Microsatellite Instability, High Tumor Mutational Burden, and Programmed Death Ligand-1 Expression Showing Pathologic Complete Response to Pembrolizumab: A Case Report
    Timothy Kwang Yong Tay et al, 2022, JCO Precision Oncology CrossRef
13. Clinical significance of signal regulatory protein alpha and T cell immunoreceptor with immunoglobulin and immunoreceptor tyrosine-based inhibition motif domain expression in undifferentiated pleomorphic sarcoma
    Shin Ishihara et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef
14. Characterization of Immune-Related Long Non-coding RNAs to Construct a Novel Signature and Predict the Prognosis and Immune Landscape of Soft Tissue Sarcoma
    Zhengjun Lin et al, 2021, Frontiers in Cell and Developmental Biology CrossRef